-
Ocugen Reverses Course From Monday's Massive Surge As COVID-19 Vaccine Partner Faces WHO Setback
Wednesday, October 27, 2021 - 1:14am | 277Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) fell 2% in Tuesday’s regular trading session after seeing strong gains on Monday. What Happened: Ocugen’s stock fell more than 2% to $9.15 in Tuesday’s trading on disappointing news related to Covaxin, the COVID-19...
-
Ocugen Stock Strikes Massive Gains Day Ahead Of Key Date: What You Should Know
Tuesday, October 26, 2021 - 1:58am | 324Shares of Ocugen Inc. (NASDAQ: OCGN) surged almost 12.3% in Monday’s regular trading session and another 38.5% in the after-hours session in anticipation of a key event taking place Tuesday. What Happened: Ocugen's shares saw notable gains on Monday ahead of a key meeting on...
-
Is This Going To Be The Next Big Factor For Ocugen (OCGN) Stock?
Wednesday, October 13, 2021 - 12:59am | 307Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 18.5% in Tuesday’s regular trading session, extending gains to a second straight day. What Happened: Ocugen’s shares extended their rally on Tuesday after it was reported that an expert panel of India’s...
-
Why Did Ocugen Stock Skyrocket On Monday?
Tuesday, October 12, 2021 - 12:49am | 328Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 8.8% in Monday’s regular trading session and also gained 11.4% in the after-hours session. What Happened: Ocugen’s shares rallied on Monday despite no company-specific news. The stock could have gained amid...
-
This 28% Short Biotech Company Has A Better 1-Year Return Than AMC, Snap, Apple And Tesla
Tuesday, September 7, 2021 - 1:08pm | 334An investment in Ocugen Inc (NASDAQ: OCGN) one year ago is undoubtedly a sight for sore eyes. Since January 2021, Ocugen stock's year-to-date return has outperformed a number of the world’s most popular companies: AMC Entertainment Holdings Inc (NYSE: AMC), Snap Inc (NYSE: SNAP), Apple...
-
What's Going On With Ocugen (OCGN) Stock Today?
Wednesday, June 30, 2021 - 5:01am | 386Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2% lower at $8.46 in the regular session, the day prior. Ocugen is the top-trending stock on Stocktwits at press time and also...
-
Ocugen's COVID-19 Vaccine Partner To Charge Twice As Much As Main Indian Rival Astrazeneca
Monday, April 26, 2021 - 2:00am | 490Biopharmaceutical company Ocugen Inc.’s (NASDAQ: OCGN) COVID-19 vaccine partner, India-based Bharat Biotech International Ltd., will charge as much as double its main rival AstraZeneca plc (NASDAQ: AZN) for its vaccines in India. What Happened: Bharat Biotech announced on Twitter it will sell...
-
Why Ocugen Shares Skyrocketed Today
Thursday, April 22, 2021 - 9:58pm | 343Ocugen Inc (NASDAQ: OCGN) shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday. What Happened: The shares surged following positive clinical data announced by a partner of Ocugen and a bullish stance taken by Roth Capital analyst Zegbeh Jallah who has a...
-
Ocugen's Partner Bharat Biotech Ramping Manufacturing To Produce 700M COVID-19 Vaccine Doses Annually
Tuesday, April 20, 2021 - 7:33am | 388India's Bharat Biotech has announced COVAXIN capacity expansion to support vaccination campaigns in India and globally amid increased COVID-19 infection cases. MoneyControl says that the capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore to reach...
-
Ocugen Skyrockets On $23M Capital Raise Issued At 46% Premium
Monday, February 8, 2021 - 6:21am | 362Ocugen Inc (NASDAQ: OCGN) rises sharply after announcing the sale of 3 million common shares at $7.65 per share in a registered direct offering, with gross proceeds of $23 million. The offer price represents a premium of 46% on the last close price of $5.25 on Friday. The...
-
Why Ocugen Stock Is Trading 74% Higher Today
Monday, February 8, 2021 - 5:54am | 195Ocugen Inc (NASDAQ: OCGN) shares traded 74.1% higher at $9.14 at press time in the pre-market session on Monday. The surge comes as the biopharmaceutical company announced the sale of 3 million shares of its common stock in a registered direct offering to healthcare-focused institutional investors...